Tag: hospital

Demand for Compounding Pharmacies in USA to Reach USD 12.79 Billion by 2036 Amid Growing Need for Personalized Therapies and Specialized Medication Solutions

NEWARK, Del., June 2, 2026 /PRNewswire/ -- The Demand for Compounding Pharmacies in USA is projected to grow from USD 6.04 billion in 2026 to...

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

AQUIPTA® (atogepant) is now approved in the European Union for the acute treatment of migraine in adults, with or without aura, and for the...

Philips announces exchange ratio for 2025 dividend

June 2, 2026

Ping An Launches “Ping An Home” Service Brand

Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy LongevityHONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates...

Ping An Launches “Ping An Home” Service Brand

Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy LongevityHONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates...

/C O R R E C T I O N — Ranok Therapeutics/

In the news release, Ranok Therapeutics Announces Positive Interim Phase 1 Data Of Its KRAS G12D Inhibitor RNK08954 In Patients With KRAS G12D-Mutated Metastatic...

Cellhub Debuts Cutting-Edge “Connected Grocery” Programs at ROFDA and FMI GroceryLab Events

Connectivity provider and Premier T-Mobile Agent Cellhub launches “Connected Grocery” 5G advanced plans for grocery retailers.

Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and...

ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that it has received clearance by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to conduct GLORA-4 study (NCT06641414), a global registrational Phase III study of lisaftoclax (APG-2575), a proprietary Bcl-2 inhibitor, in combination with azacitidine (AZA), for the treatment of patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS).

Public health notice: Outbreak of Salmonella infections linked to various brands of pistachios and pistachio-containing products

August 15, 2025: Update OTTAWA, ON, Aug. 15, 2025 /CNW/ - This outbreak investigation is ongoing. The public health notice will be updated as the investigation...

Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001

Jabez Biosciences Announces Opening of Second Clinical Site in Phase 1 study in Solid Tumors and NHL

InnovAge Florida PACE – Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa

Hanson Builders Hosts Ribbon Cutting for St. Jude Dream Home® Showplace

MAPLE GROVE, Minn., Aug. 15, 2025 /PRNewswire/ -- Hanson Builders, a leading Minnesota home construction company, hosted a ribbon cutting ceremony and VIP Sneak Peek...

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Instinct Science Named to the 2025 Inc. 5000 List of Fastest-Growing Private Companies

PHILADELPHIA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Instinct Science, a leading innovator in veterinary workflow, decision support, education, and practice management software, has been named to the Inc. 5000 list of the fastest-growing private companies in America, earning the #388 spot overall, ranking #6 in Pennsylvania, and #37 in Software companies nationwide.

Verato Named 2026 Healthcare & Life Sciences Snowflake Product Partner of the Year

Mayo Clinic and Microsoft collaborate to develop a frontier AI model for healthcare

Immuta Launches New Agentic Data Access Capabilities on Snowflake AI Data Cloud

Tag: hospital

Demand for Compounding Pharmacies in USA to Reach USD 12.79 Billion by 2036 Amid Growing Need for Personalized Therapies and Specialized Medication Solutions

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

Philips announces exchange ratio for 2025 dividend

Ping An Launches “Ping An Home” Service Brand

Ping An Launches “Ping An Home” Service Brand

/C O R R E C T I O N — Ranok Therapeutics/

Cellhub Debuts Cutting-Edge “Connected Grocery” Programs at ROFDA and FMI GroceryLab Events

Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and...

Public health notice: Outbreak of Salmonella infections linked to various brands of pistachios and pistachio-containing products

Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001

InnovAge Florida PACE – Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa

Hanson Builders Hosts Ribbon Cutting for St. Jude Dream Home® Showplace

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Instinct Science Named to the 2025 Inc. 5000 List of Fastest-Growing Private Companies

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us